Retrieve available abstracts of 10 articles: HTML format
Single Articles
June 2025
ZIAI WC, Tsivgoulis G Timing of anticoagulation after ischaemic stroke and atrial fibrillation: better
swift than sorry.
Lancet. 2025 Jun 23:S0140-6736(25)00676-2. doi: 10.1016/S0140-6736(25)00676. PubMed
DEHBI HM, Fischer U, Asberg S, Milling TJ, et al Collaboration on the optimal timing of anticoagulation after ischaemic stroke and
atrial fibrillation: a systematic review and prospective individual participant
data meta-analysis of randomised controlled trials (CATALYST).
Lancet. 2025 Jun 23:S0140-6736(25)00439-8. doi: 10.1016/S0140-6736(25)00439. PubMedAbstract available
February 2025
SALMAN RA, Shoamanesh A Towards definitive evidence about anticoagulation for atrial fibrillation after
intracranial haemorrhage.
Lancet. 2025 Feb 26:S0140-6736(25)00366-6. doi: 10.1016/S0140-6736(25)00366. PubMed
VELTKAMP R, Korompoki E, Harvey KH, Harvey ER, et al Direct oral anticoagulants versus no anticoagulation for the prevention of stroke
in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF):
a multicentre, open-label, randomised, phase 3 trial.
Lancet. 2025 Feb 26:S0140-6736(25)00333-2. doi: 10.1016/S0140-6736(25)00333. PubMedAbstract available
October 2024
WERRING DJ, Dehbi HM, Ahmed N, Arram L, et al Optimal timing of anticoagulation after acute ischaemic stroke with atrial
fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised
controlled trial.
Lancet. 2024 Oct 23:S0140-6736(24)02197-4. doi: 10.1016/S0140-6736(24)02197. PubMedAbstract available
SANDSET EC, de Sousa DA Optimal anticoagulation timing after ischaemic stroke in patients with atrial
fibrillation.
Lancet. 2024 Oct 23:S0140-6736(24)02259-1. doi: 10.1016/S0140-6736(24)02259. PubMed
September 2024
PREVEL R, Boyer A, Gruson D, Orieux A, et al Catheter ablation for atrial fibrillation, atrio-oesophageal fistula, cerebral
air embolism, and hyperbaric oxygen therapy.
Lancet. 2024;404:1051-1052. PubMed
November 2023
HEERSPINK HJL, Kiyosue A, Wheeler DC, Lin M, et al Zibotentan in combination with dapagliflozin compared with dapagliflozin in
patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised,
active-controlled, phase 2b, clinical trial.
Lancet. 2023 Nov 2:S0140-6736(23)02230-4. doi: 10.1016/S0140-6736(23)02230. PubMedAbstract available
September 2023
FUJIMOTO Y, Iwasaki YK, Asai K Pericardial-oesophageal fistula after ablation for atrial fibrillation.
Lancet. 2023;402:882. PubMed
August 2023
WILKOFF BL, Filippatos G, Leclercq C, Gold MR, et al Adaptive versus conventional cardiac resynchronisation therapy in patients with
heart failure (AdaptResponse): a global, prospective, randomised controlled
trial.
Lancet. 2023 Aug 24:S0140-6736(23)00912-1. doi: 10.1016/S0140-6736(23)00912. PubMedAbstract available